Eurofins-Cerep SA

Paris Stock Exchange ALECR.PA

Eurofins-Cerep SA Operating Income Margin for the year ending December 31, 2023: 14.66%

Eurofins-Cerep SA Operating Income Margin is 14.66% for the year ending December 31, 2023, a -39.14% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Eurofins-Cerep SA Operating Income Margin for the year ending December 31, 2022 was 24.09%, a -1.04% change year over year.
  • Eurofins-Cerep SA Operating Income Margin for the year ending December 31, 2021 was 24.35%, a 43.45% change year over year.
  • Eurofins-Cerep SA Operating Income Margin for the year ending December 31, 2020 was 16.97%, a 24.51% change year over year.
  • Eurofins-Cerep SA Operating Income Margin for the year ending December 31, 2019 was 13.63%, a -30.37% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
SV Wall Street
Paris Stock Exchange: ALECR.PA

Eurofins-Cerep SA

CEO Mr. Damien Vielliard
IPO Date April 12, 2000
Location France
Headquarters Le Bois l'Evêque
Employees 209
Sector Healthcare
Industries
Biotechnology Bitcoin & Crypto Clinical Trials Fintech Investment Banking & Asset Management Pharmaceuticals Rating Agencies Research & Consulting
Description

Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.

StockViz Staff

February 7, 2025

Any question? Send us an email